Quit2Heal Smartphone App in Helping Cancer Patients Quit Smoking

Fred Hutchinson Cancer Center (FHCC)

Status and phase: Active, not recruiting; Phase 3

Conditions: Malignant Solid Neoplasm; Hematopoietic and Lymphoid System Neoplasm

Treatments: Other: Survey Administration; Behavioral: Quit2Heal; Behavioral: QuitGuide

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT04409236

NCI-2020-03442 (Other Grant/Funding Number)

10432 (Other Identifier)

RG1007577

R01CA253975 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This phase III trial compares the Quit2Heal smoking cessation smartphone application (app) to the QuitGuide app in helping cancer patients quit smoking. Both apps provide tools to cope with urges to smoke, step-by-step guides for quitting smoking, help in planning for quitting and staying tobacco-free, and scientifically-based recommendations for how to select medications that aid in smoking cessation.

Full description

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I: Patients receive the Quit2Heal app and are encouraged to use it frequently. During the entire 12-month follow-up period, the app will remain fully available anytime study participants wish to use it.

ARM II: Patients receive the QuitGuide app and are encouraged to use it frequently. During the entire 12-month follow-up period, the app will remain fully available anytime study participants wish to use it.

After randomization, patients are followed up at 3, 6, and 12 months.

Enrollment: 427 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 18 or older
• Diagnosed with cancer within the past 24 months or currently receiving or planning to receive cancer treatment in the next 3 months
• Smoked a cigarette (even a puff) in the past 30 days
• Interested in learning skills to quit smoking
• Willing to be randomly assigned to either smartphone application
• Live in the United States and will remain in the United States (US) for the next 12 months
• Have at least daily access to their own smartphone
• Know how to download a smartphone application
• Be willing and able to read English
• Not currently (i.e., within past 30 days) using other smoking cessation interventions
• Have never participated in our prior research trials
• Have never used the National Cancer Institute (NCI)'s QuitGuide app
• Being willing to complete a follow-up survey at 3, 6, and 12 months post-randomization
• Providing email, phone number(s), and mailing address

Exclusion criteria

• Currently (i.e., within past 30 days) using other smoking cessation interventions
• Has participated in our prior research trials
• Has used the NCI's QuitGuide app
• Not willing to complete a follow-up survey at 3, 6, and 12 months post-randomization
• Not providing email, phone number(s), and mailing address

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

427 participants in 2 patient groups

Arm I (Quit2Heal app)

Experimental group

Description:

Patients receive the Quit2Heal app and are encouraged to use it frequently. During the entire 12-month follow-up period, the app will remain fully available anytime study participants wish to use it.

Treatment:

Behavioral: Quit2Heal

Other: Survey Administration

Arm II (QuitGuide app)

Active Comparator group

Description:

Patients receive the QuitGuide app and are encouraged to use it frequently. During the entire 12-month follow-up period, the app will remain fully available anytime study participants wish to use it.

Treatment:

Behavioral: QuitGuide

Other: Survey Administration